Sort   by:  
 Page size 
UnknownSymptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.
Not available
S-EPMC4872028 | biostudies-literature
UnknownFor uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach.
Not available
S-EPMC4947373 | biostudies-literature
UnknownFeasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.
Not available
S-EPMC6209091 | biostudies-literature
UnknownScreening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
Not available
S-EPMC3776923 | biostudies-literature
UnknownAntiemetics: American Society of Clinical Oncology clinical practice guideline update.
Not available
S-EPMC4876353 | biostudies-literature
UnknownCabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
Not available
S-EPMC4383838 | biostudies-literature
UnknownSystemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.
Not available
S-EPMC4876355 | biostudies-literature
UnknownTrial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Not available
S-EPMC4872347 | biostudies-literature
Sort   by:  
 Page size